ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI’s RAPID Program; RFA, Pas Avilable

May 14, 1999

In Brief: Senate Subcommittee Recommends $1 .52 Billion

September 25, 1987

IOM Calls for Freeze On Med School Classes, Cuts of Residencies

February 2, 1996

Nelvis Castro To Serve As Acting OCC Chief; HHS Selects ANA President Malone.

January 7, 2000

Ratain To Lead New Center For Personalized Therapeutics At University of Chicago. Report Calls For Better Risk Stratification And New Name For DCIS.

January 22, 2010

NCI Approved Clinical Trials

May 28, 2010